Phase I/II open label dose escalation study of the safety, pharmacokinetics, and preliminary efficacy of SCI6D6.5 as a single agent in patients with recurrent small cell lung cancer.
Clinical Trial Grant
Awarded By
Stem CentRx, Inc.
Start Date
October 1, 2013
End Date
March 23, 2018
Awarded By
Stem CentRx, Inc.
Start Date
October 1, 2013
End Date
March 23, 2018